IGC Pharma
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell IGC Pharma and other ETFs, options, and stocks.About IGC
IGC Pharma, Inc. is a clinical-stage pharmaceutical company that is focused on Alzheimer's disease, developing innovative solutions to address this devastating illness. It has two investigational drug assets targeting Alzheimer's disease: IGC-AD1, which is in a Phase 2 clinical trial as a treatment for agitation in dementia due to Alzheimer's and TGR-63 that is in pre-clinical development.
IGC Key Statistics
Stock Snapshot
As of today, IGC Pharma(IGC) shares are valued at $0.29. The company's market cap stands at 28.53M, with a P/E ratio of -4.54.
On 2026-06-16, IGC Pharma(IGC) stock moved within a range of $0.28 to $0.29. With shares now at $0.29, the stock is trading +1.1% above its intraday low and -2.4% below the session's peak.
Trading activity shows a volume of 682.45K, compared to an average daily volume of 695.25K.
The stock's 52-week range extends from a low of $0.24 to a high of $0.50.
The stock's 52-week range extends from a low of $0.24 to a high of $0.50.
IGC News
IGC Pharma (IGC) announced that its Phase 2 Calma trial evaluating IGC-AD1 for agitation associated with Alzheimer’s dementia has reached the Company’s previous...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.